TERT mutation

Glioblastoma as per molecular alterations (EGFRamp, gain of chromosome 7 and loss of chromosome 10 and TERT promoter mutation) (@PathIsArt)

A hypothesis-generating analysis on the role of TERT promoter mutation in advanced #UrothelialCarcinoma treated with immunotherapy. #BeyondTheAbstract with @vmollica7, Paola Valeria Marchese, MD, and @fmassari79 > https://t.co/RiXbj55eVU (@urotoday)

A hypothesis-generating analysis on the role of TERT promoter mutation in advanced #UrothelialCarcinoma treated with immunotherapy. #BeyondTheAbstract with @vmollica7, Paola Valeria Marchese, MD, and @fmassari79 > https://t.co/RiXbj55eVU (@urotoday)

Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers The story goes on @PaolaVMarchese @vmollica7 https://t.co/tt0lgUqQ3z (@fmassari79)

A hypothesis-generating analysis on the role of TERT promoter mutation in advanced #UrothelialCarcinoma treated with immunotherapy. #BeyondTheAbstract with @vmollica7, Paola Valeria Marchese, MD, and @fmassari79 > https://t.co/RiXbj55MLs (@urotoday)

Which role of TERT promoter mutation in advanced #UrothelialCarcinoma ? Our experience at @Unibo with @PaolaVMarchese and @vmollica7 (@fmassari79)

Mutations in TPP1 promoter cooperate with TERT promoter mutations to lengthen telomeres in melanoma https://t.co/G98kK0rZqD. Congratulations to #Pitt authors including @jmkirkwood and BSeynaaeve for seminal work. @UPMCHillmanCC (@diwakardavar)

A Hypothesis-Generating Analysis on the Role of TERT Promoter Mutation in Advanced Urothelial Carcinoma Treated with Immunotherapy - Beyond the Abstract ⁦@fmassari79⁩ ⁦@PaolaVMarchese⁩ https://t.co/uaEfjUA3Rm (@vmollica7)

Fascinating talk by Dr Costello of @NeurosurgUCSF today @WakeCancer @AtriumHealth Brain Tumor Retreat. Review of TERT promoter mutation & impact on tumor immortality #btsm (@AshleySumrallMD)

Thyroid Health Blog: TERT promoter mutations in thyroid cancers https://t.co/A2RtMnP4Tb Check out this great summary of TERT mutations in thyroid cancer by @inigo_landa at BWH/DFCI (@MelissaGLechner)

Intravascular thrombi; IDH wildtype astrocytoma, most likely CNS WHO grade 4 and therefore GBM (depending on presence of necrosis, MVP, p-TERT mutation, EGFR amp, and/or chr7+/chr10-). (@CheySlocum)

Cool new story by @FurnariLab and colleagues demonstrating that TERT promoter mutation facilitates glioblastoma growth upon reduced telomere length. This paper is now online @NeuroOnc. https://t.co/Jl3TvOdHWz (@GutmannLab)

TERT promoter mutations predict benefit from immunotherapy in patients with #UrothelialCancer. #ExpertCommentary from @FaltasLab @WCMEnglanderIPM of a recent study by @ivandk3 et al., published in the @jitcancer. #ReadNow on UroToday > https://t.co/3HBxUetZDu @WeillCornell (@urotoday)

TERT promoter mutations predict benefit from immunotherapy in patients with #UrothelialCancer. #ExpertCommentary from @FaltasLab @WCMEnglanderIPM of a recent study by @ivandk3 et al., published in the @jitcancer. #ReadNow on UroToday > https://t.co/3HBxUeLB24 @WeillCornell (@urotoday)

Don't miss the latest @urotoday Expert Commentary by @WCMEnglanderIPM Member Dr. Bishoy Faltas (@FaltasLab) "TERT Promoter Mutations Predict Benefit From Immunotherapy in Patients With Urothelial Cancer." #PrecisionMedicine https://t.co/YGMIUhqZ7j (@WCMEnglanderIPM)

TERT promoter mutations predict benefit from immunotherapy in patients with #UrothelialCancer. #ExpertCommentary from @FaltasLab @WCMEnglanderIPM of a recent study by @ivandk3 et al., published in the @jitcancer. #ReadNow on UroToday > https://t.co/3HBxUeLB24 @WeillCornell (@urotoday)

Telomerase reverse transcriptase #TERT promoter mutations in primary adenocarcinoma of bladder and #UrothelialCarcinoma with glandular differentiation. #ExpertCommentary of a study by @LiangChengMD et al. in @ModernPathology > https://t.co/2U4Q3DZSat @FaltasLab @WCMEnglanderIPM (@urotoday)

Telomerase reverse transcriptase #TERT promoter mutations in primary adenocarcinoma of bladder and #UrothelialCarcinoma with glandular differentiation. #ExpertCommentary of a study by @LiangChengMD et al. in @ModernPathology > https://t.co/2U4Q3DZSat @FaltasLab @WCMEnglanderIPM (@urotoday)

Telomerase reverse transcriptase #TERT promoter mutations in primary adenocarcinoma of bladder and #UrothelialCarcinoma with glandular differentiation. #ExpertCommentary of a study by @LiangChengMD et al. in @ModernPathology > https://t.co/2U4Q3DZSat @FaltasLab @WCMEnglanderIPM (@urotoday)